Trial intelligence / Profile preview

Azithromycin for Prevention of Asthma Attacks in Chronic Asthma

IRCT20100102002954N24Phase 3Completed

Sponsor
Shahroud University of Medical Sciences
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of azithromycin in asthma, sponsored by Shahroud University of Medical Sciences. Started May 2021; status: completed.

02

Drugs

azithromycin
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT20100102002954N24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100102002954N24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call